[1] S. L. Luo, Z. Y. Yang, X. Tan, Y. Wang, Y. P. Zeng, Y. Wang, C. M. Li and R. Li, “Multifunctional photosensitizer grafted on polyethylene glycol and polyethylenimine dual-functionalized nanographene oxide for cancer-targeted near-infrared imaging and synergistic phototherapy," ACS. Appl. Mater. Interfaces 8, 17176–17186 (2016).

[2] N. Li, T. T. Li, C. Hu, X. M. Lei, Y. P. Zuo and H. Y. Han, “Targeted near-infrared fluorescent turn-on nanoprobe for activatable imaging and effective phototherapy of cancer cells," ACS. Appl. Mater. Interfaces 8, 15013–15023 (2016).

[3] R. R. Guo, H. B. Peng, Y. Tian, S. Shen and W. L. Yang, “Mitochondria-targeting magnetic composite nanoparticles for enhanced phototherapy of cancer," Small 12, 4541–4552 (2016).

[4] Z. H. Sheng, D. H. Hu, M. B. Zheng, P. F. Zhao, H. L. Liu, D. Y. Gao, P. Gong, G. H. Gao, P. F. Zhang, Y. F. Ma and L. T. Cai, “Smart human serum albumin-indocyanine green nanoparticles generated by programmed assembly for dual-modal imaging-guided cancer synergistic phototherapy," ACS. Nano 8, 12310–12322 (2014).

[5] R. Chen, X. Wang, X. K. Yao, X. C. Zheng, J. Wang and X. Q. Jiang, “Near-IR-triggered photothermal/photodynamic dual-modality therapy system via chitosan hybrid nanosphere," Biomaterials 34, 8314–8322 (2013).

[6] J. P. Celli, B. Q. Spring, I. Rizvi, C. L. Evans, K. S. Samkoe, S. Verma, B. W. Pogue and T. Hasan, “Imaging and photodynamic therapy: Mechanisms, monitoring, and optimization," Chem. Rev. 110, 2795–2838 (2010).

[7] E. Boisselier and D. Astruc, “Gold nanoparticles in nanomedicine: Preparations, imaging, diagnostics, therapies and toxicity," Chem. Soc. Rev. 38, 1759–1782 (2009).

[8] E. J. Sanchez-Barcelo and M. D. Mediavilla, “Recent patents on light-based therapies: Photodynamic therapy, photothermal therapy and photoimmunotherapy," Recent. Pat. Endocr. Metab. Immune Drug Discov. 8, 1–8 (2014).

[9] L. W. Lin, L. Xiong, Y. Wen, S. L. Lei, X. F. Deng, Z. P. Liu, W. Chen and X. G. Miao, “Active targeting of nano-photosensitizer delivery systems for photodynamic therapy of cancer stem cells," J. Biomed. Nanotechnol. 11, 531–554 (2015).

[10] T. G. St Denis and M. R. Hamblin, “Synthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapy," Bioanalysis 5, 1099–1114 (2013).

[11] N. V. Kudinova and T. T. Berezov, “Photodynamic therapy: Search for ideal photosensitizer," Biomed. Khim. 55, 558–569 (2009).

[12] C. W. Chung, C. W. Choi, Y. I. Jeong and D. H. Kang, “Nano-self assembled photosensitizer composed of methoxy poly(ethylene glycol)-conjugated chlorin e6 for enhanced photosensing of HCT116 cells," J. Nanosci. Nanotechnol. 16, 1379–1383 (2016).

[13] W. X. Hou, X. Zhao, X. Q. Qian, F. Pan, C. L. Zhang, Y. M. Yang, J. M. de la Fuente and D. X. Cui, “pH-sensitive self-assembling nanoparticles for tumor near-infrared fluorescence imaging and chemo-photodynamic combination therapy," Nanoscale 8, 104–116 (2016).

[14] I. E. Furre, S. Shahzidi, Z. Luksiene, M. T. Moller, E. Borgen, J. Morgan, K. Tkacz-Stachowska, J. M. Nesland and Q. Peng, “Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells," Cancer. Res. 65, 11051–11060 (2005).

[15] Z. C. Fan, X. J. Cui, D. Wei, W. Liu, B. H. Li, H. He, H. M. Ye, N. S. Zhu and X. B. Wei, “eEF1A1 binds and enriches protoporphyrin IX in cancer cells in 5-aminolevulinic acid-based photodynamic therapy," Sci. Rep. 6, 25353 (2016).

[16] W. B. Wu, D. Mao, F. Hu, S. D. Xu, C. Chen, C. J. Zhang, X. M. Cheng, Y. Y. Yuan, D. Ding, D. L. Kong and B. Liu, “A highly e±cient and photostable photosensitizer with near-infrared aggregation-induced emission for image-guided photodynamic anticancer therapy," Adv. Mater. 29 (2017).

[17] M. Berndt-Paetz, A. Weimann, N. Sieger, S. Schastak, Y. M. Riyad, J. Griebel, V. K. A. Arthanareeswaran, J. U. Stolzenburg and J. Neuhaus, “Tetrahydroporphyrin-tetratosylat (THPTS): A near-infrared photosensitizer for targeted and effcient photodynamic therapy (PDT) of human bladder carcinoma," Photodiagnosis. Photodyn. Ther. 18, 244–251 (2017).

[18] T. Desmettre, J. M. Devoisselle and S. Mordon, “Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography," Surv. Ophthalmol. 45, 15–27 (2000).

[19] R. Radzi, T. Osaki, T. T. suka, T. Imagama, S. Minami, Y. Nakayama and Y. Okamoto, “Photodynamic hyperthermal therapy with indocyanine green (ICG) induces apoptosis and cell cycle arrest in B16F10 murine melanoma cells," J. Vet. Med. Sci. 74, 545–551 (2012).

[20] S. Luo, X. Tan, S. Fang, Y. Wang, T. Liu, X. Wang, Y. Yuan, H. Sun, Q. Qi and C. Shi, “Mitochondriatargeted small-molecule fluorophores for dual modal cancer phototherapy," Adv. Funct. Mater. 26, 2826–2835 (2016).